Immunic Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-93.61	-120.41	-92.95	-44.02	-34.93	-11.54	-52.08	-40.97	-52.02	-56.82	Upgrade
Depreciation & Amortization	0.11	0.08	0.09	0.04	0.05	0.02	1	1.81	1.33	1.09	Upgrade
Share-Based Compensation	7.1	7.93	5.95	2.75	6.51	0	5.74	4.68	4.03	2.51	Upgrade
Other Operating Activities	15.57	47.26	3.68	-4.89	-0.17	1.79	4.95	-1.29	-3.29	3.25	Upgrade
Operating Cash Flow	-70.83	-65.14	-83.23	-46.12	-28.55	-9.74	-40.4	-35.77	-49.95	-40.83	Upgrade
Capital Expenditures	-0.33	-0.11	-0.07	-0.15	-0.02	-0.03	-0.68	-0.55	-2.34	-1.41	Upgrade
Acquisitions	0	0	0	0	10.55	0	0	0	0	0	Upgrade
Change in Investments	9.8	-9.63	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	0.53	1.06	-0.63	Upgrade
Investing Cash Flow	9.46	-9.74	-0.07	-0.15	10.54	-0.03	-0.68	-0.02	-1.28	-2.04	Upgrade
Share Issuance / Repurchase	0.98	95.76	42.84	144.43	35.17	0	38	12.39	32.7	88.75	Upgrade
Other Financing Activities	0.05	-	-	-	-0.27	19.26	-0.02	-0.01	-0.28	18.17	Upgrade
Financing Cash Flow	1.03	95.76	42.84	144.43	34.9	19.26	37.98	12.37	32.42	106.92	Upgrade
Exchange Rate Effect	0.26	-0.99	-0.13	-0.08	-0.59	-0.92	0	-0	-0.01	-0	Upgrade
Net Cash Flow	-60.07	19.88	-40.59	98.08	16.3	8.57	-3.09	-23.43	-18.82	64.05	Upgrade
Free Cash Flow	-71.16	-65.26	-83.3	-46.27	-28.56	-9.77	-41.08	-36.33	-52.29	-42.23	Upgrade
Free Cash Flow Per Share	-1.61	-2.05	-3.52	-2.95	-3.70	-11.54	-41.22	-46.30	-83.16	-105.23	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).